Latest Content

Brittney Nichols highlights the need for early detection and stresses that lung cancer is not only caused by smoking; anyone can develop the disease.

The FDA has granted breakthrough therapy designation to ficerafusp alfa with Keytruda for some patients with head and neck squamous cell carcinoma.

CURE spoke with Dr. Komal Jhaveri about the findings of the EMBER-3 clinical trial.

Pelvic health therapist Dr. Alison Ankiewicz helps women manage pain, intimacy issues and bladder or bowel problems that can follow cancer treatment.

CURE spoke with melanoma survivor Betsy Hamlin about her experience with subcutaneous Keytruda in a clinical trial.

Dr. Evan Garfein discussed OnPlant, a 3D breast model, and stressed timely reconstructive care for all patients during Breast Cancer Awareness Month.

Dr. Ravi Munver discusses how minimally invasive techniques allow patients to preserve kidney function and practical guidance for navigating treatment.

This guide provides a supportive overview of stage 2 melanoma, covering diagnosis, treatment options, and key questions for your medical team.

Sarcoma is a rare cancer of connective tissues that requires specialized diagnosis and care tailored to tumor type, stage, and patient needs.

I share my journey facing breast cancer at 39, learning my numbers, trusting my doctor, and becoming my own advocate for informed treatment choices.

Jennie Smythe continues the conversation following her initial discussion on early detection self-advocacy during Breast Cancer Awareness Month.

The FDA granted fast track status to ADCE-D01, a targeted drug in early trials for soft tissue sarcoma, to speed development and review.

From diagnosis to treatment, here is what patients need to know about stage 1 testicular cancer.